Elie Tabet

Elie Tabet has over two decades of experience in drug substance development and medicinal chemistry at GSK, where roles have included Investigator in Drug Substance Development, Investigator in the Flexible Discovery Unit, and Investigator in Exploratory Development Sciences since 2010. Prior experience as Principal Scientist in Chemical Development from 2003 to 2009 highlights significant contributions in synthesizing lead compounds and scaling up processes under GMP conditions. Elie Tabet possesses expertise in route scouting, technical transfers, and reaction management in both fixed and flow systems, and is proficient in various chemical software and chromatography equipment. Academic achievements include a postdoctoral degree in organic chemistry from Stanford University and a Ph.D. from the University of North Carolina at Chapel Hill, complemented by a B.A. in chemistry from Connecticut College, graduating Summa Cum Laude.